Ronald M. Lindsay

Ronald M. Lindsay

Chief Executive Officer bei Zebra Biologics, Inc.

76 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Ronald M.
Lindsay
was the founder of Neurocentrx Pharma Ltd.
founded in 2008, where he served as Executive Chairman from 2008 to 2013.
Currently, he holds the position of Chairman & Chief Executive Officer at Zebra Biologics, Inc., and Director at HistoRx, Inc. and Depixus SAS.
Dr. Lindsay has previously worked as a Director at ArQule, Inc., Neuro3D SA, and Sequenom, Inc. where he served as Director from 2003 to 2016.
He has also worked as Vice President-Neurobiology at Regeneron Pharmaceuticals, Inc. from 1989 to 1997, Senior Vice President-Biotherapeutics at Millennium Pharmaceuticals, Inc. from 1997 to 2000, and CSO, Vice President-Research & Development at diaDexus, Inc. from 2000 to 2004.
Additionally, he has worked as Head-Cell Biology at Sandoz Institute for Medical Research from 1984 to 1989.
Dr. Lindsay has an undergraduate degree from the University of Glasgow and a doctorate from the University of Calgary.

Aktive Positionen von Ronald M. Lindsay

UnternehmenPositionBeginn
Director/Board Member -
Chief Executive Officer -
Director/Board Member -
Alle aktiven Positionen von Ronald M. Lindsay

Ehemalige bekannte Positionen von Ronald M. Lindsay

UnternehmenPositionEnde
SEQUENOM, INC. President 21.12.2009
Director/Board Member 21.10.2013
Founder 01.01.2013
Chief Tech/Sci/R&D Officer 01.01.2004
Corporate Officer/Principal 01.01.2000
Sehen Sie sich die Erfahrung von Ronald M. Lindsay im Detail an

Ausbildung von Ronald M. Lindsay

University of Glasgow Undergraduate Degree
University of Calgary Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Ronald M. Lindsay im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen1
REGENERON PHARMACEUTICALS, INC.

Health Technology

Private Unternehmen10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Sandoz Institute for Medical Research

Health Technology

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Ronald M. Lindsay